PT2302063T - Minicélulas intactas, como vetores para a transferência de adn e terapêutica genética in vitro e in vivo - Google Patents

Minicélulas intactas, como vetores para a transferência de adn e terapêutica genética in vitro e in vivo

Info

Publication number
PT2302063T
PT2302063T PT101762094T PT10176209T PT2302063T PT 2302063 T PT2302063 T PT 2302063T PT 101762094 T PT101762094 T PT 101762094T PT 10176209 T PT10176209 T PT 10176209T PT 2302063 T PT2302063 T PT 2302063T
Authority
PT
Portugal
Prior art keywords
minicells
vectors
vitro
vivo
gene therapy
Prior art date
Application number
PT101762094T
Other languages
English (en)
Inventor
Himanshu Brahmbhatt
Macdiarmid Jennifer
Original Assignee
Engeneic Molecular Delivery Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Engeneic Molecular Delivery Pty Ltd filed Critical Engeneic Molecular Delivery Pty Ltd
Publication of PT2302063T publication Critical patent/PT2302063T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT101762094T 2001-10-15 2002-10-15 Minicélulas intactas, como vetores para a transferência de adn e terapêutica genética in vitro e in vivo PT2302063T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32880101P 2001-10-15 2001-10-15

Publications (1)

Publication Number Publication Date
PT2302063T true PT2302063T (pt) 2016-07-28

Family

ID=23282498

Family Applications (2)

Application Number Title Priority Date Filing Date
PT101762094T PT2302063T (pt) 2001-10-15 2002-10-15 Minicélulas intactas, como vetores para a transferência de adn e terapêutica genética in vitro e in vivo
PT02783361T PT1446489E (pt) 2001-10-15 2002-10-15 Minicélulas intactas, como vectores para a transferência de adn e terapia genética in vitro e in vivo

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT02783361T PT1446489E (pt) 2001-10-15 2002-10-15 Minicélulas intactas, como vectores para a transferência de adn e terapia genética in vitro e in vivo

Country Status (12)

Country Link
US (4) US20050222057A1 (pt)
EP (2) EP1446489B1 (pt)
JP (1) JP4458846B2 (pt)
CN (2) CN102172406B (pt)
AT (1) ATE541940T1 (pt)
AU (1) AU2002347426B2 (pt)
CA (2) CA2775218C (pt)
DK (1) DK1446489T3 (pt)
ES (2) ES2380612T3 (pt)
HK (1) HK1156069A1 (pt)
PT (2) PT2302063T (pt)
WO (1) WO2003033519A2 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396822B2 (en) 2001-05-24 2008-07-08 Vaxiion Therapeutics, Inc. Immunogenic minicells and methods of use
US20030194798A1 (en) 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
ES2380612T3 (es) * 2001-10-15 2012-05-16 Engeneic Molecular Delivery Pty Ltd. Minicélulas intactas como vectores para transferencia de ADN y terapia génica in vitro e in vivo
EP2272946B9 (en) * 2002-02-25 2015-06-24 Vaxiion Therapeutics, LLC Minicell compositions and methods
US7611885B2 (en) 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
WO2005047504A1 (en) * 2003-11-07 2005-05-26 The Board Of Trustees Of The University Of Illinois Induction of cellular senescence by cdk4 disruption for tumor suppression and regression
JP4332558B2 (ja) * 2003-12-09 2009-09-16 エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド 細菌由来のインタクトなミニ細胞を介した非食作用性哺乳動物細胞への標的化遺伝子送達
US8772013B2 (en) 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
ME02251B (me) * 2004-02-02 2015-12-31 Engeneic Molecular Delivery Pty Ltd Kompozicije i postupci in vitro i in vivo, ciljanog oslobađanja leka u ćelijama sisara, preko intaktnih minićelija izvedenih iz bakterija
GB0404209D0 (en) * 2004-02-25 2004-03-31 Uws Ventures Ltd Materials and methods for treatment of allergic disease
US8691963B2 (en) 2004-08-26 2014-04-08 Engeneic Molecular Delivery Pty. Ltd. Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
PT2040725E (pt) 2006-06-23 2014-04-24 Engeneic Molecular Delivery Pty Ltd Distribuição dirigida de fármacos, ácidos nucleicos terapêuticos e ácidos nucleicos funcionais a células de mamífero através de células bacterianas mortas intactas
PL2145002T3 (pl) 2007-03-30 2015-06-30 Engeneic Molecular Delivery Pty Ltd Nienaruszone minikomórki pochodzenia bakteryjnego, które obejmują funkcjonalny kwas nukleinowy pozbawiony plazmidu do dostarczania in vivo do komórek ssaczych
US20080286211A1 (en) * 2007-04-27 2008-11-20 Barker Nicholas P Using mucin glycoproteins in combination with therapeutic agents to treat epithelial lesions and disorders of impaired mucin function
CA2729545C (en) * 2008-06-25 2019-07-09 Vaxiion Therapeutics, Inc. Regulated genetic suicide mechanism compositions and methods
JP2010063404A (ja) * 2008-09-10 2010-03-25 Olympus Corp 幹細胞の分離方法
EP2485764A4 (en) * 2009-10-09 2014-01-29 Childrens Medical Center WHOLE CELL VACCINE WITH SELECTIVE DISSOCIATION
AU2012217728B2 (en) 2011-02-15 2017-04-27 Vaxiion Therapeutics, Llc Therapeutic compositions and methods for antibody and Fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
SG10201601349XA (en) * 2011-12-13 2016-03-30 Engeneic Molecular Delivery Pty Ltd Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
EP2807180B1 (en) 2012-01-24 2018-03-28 InterK Peptide Therapeutics Limited Peptide agents for cancer therapy
EA032740B1 (ru) 2013-10-04 2019-07-31 Энджинеик Молекьюлар Деливери Пти Лтд Способ лечения опухоли у индивидуума и набор для осуществления способа
JP7029957B2 (ja) 2014-10-03 2022-03-04 エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド インタクトな細菌由来のベシクルへの低分子化合物の充填の向上
US11185555B2 (en) 2016-04-11 2021-11-30 Noah James Harrison Method to kill pathogenic microbes in a patient
JP7213798B2 (ja) 2016-10-06 2023-01-27 エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド 核酸アジュバントを送達するための細菌ミニ細胞およびその使用方法
US11624061B2 (en) 2017-04-28 2023-04-11 Agrospheres, Inc. Compositions and methods for enzyme immobilization
EP3615659A4 (en) 2017-04-28 2021-01-06 Agrospheres, Inc. COMPOSITIONS AND METHODS OF ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS
WO2019060903A1 (en) 2017-09-25 2019-03-28 Agrospheres, Inc. COMPOSITIONS AND METHODS FOR PRODUCING AND EVOLVING ADMINISTRATION OF BIOLOGICAL PRODUCTS
SG11202100507PA (en) 2018-07-23 2021-02-25 Engeneic Molecular Delivery Pty Ltd Compositions comprising bacterially derived minicells and methods of using the same
CN109540890A (zh) * 2018-11-27 2019-03-29 湖南品胜生物技术有限公司 一种基于细胞显微镜图像的dna定量分析方法
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
EP4168025A1 (en) * 2020-06-17 2023-04-26 Flagship Pioneering Innovations VI, LLC Methods for manufacturing adas
WO2022256427A1 (en) * 2021-06-01 2022-12-08 University Of Virginia Patent Foundation Minicells from highly genome reduced escherichia coli: cytoplasmic and surface expression of recombinant proteins and incorporation in the minicells

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497796A (en) 1980-03-26 1985-02-05 The Regents Of The University Of California Gene transfer in intact mammals
GB8611832D0 (en) 1986-05-15 1986-06-25 Holland I B Polypeptide
US5037743A (en) 1988-08-05 1991-08-06 Zymogenetics, Inc. BAR1 secretion signal
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5221479A (en) * 1991-02-15 1993-06-22 Fuji Photo Film Co., Ltd. Filtration system
WO1995021191A1 (en) 1994-02-04 1995-08-10 William Ward Bioluminescent indicator based upon the expression of a gene for a modified green-fluorescent protein
AU6762498A (en) 1997-03-19 1998-10-12 Zymogenetics Inc. Secreted salivary zsig32 polypeptides
US7125679B2 (en) * 2001-03-07 2006-10-24 Children's Medical Center Corporation Methods to screen peptide libraries using minicell display
US20030194798A1 (en) * 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
ES2380612T3 (es) * 2001-10-15 2012-05-16 Engeneic Molecular Delivery Pty Ltd. Minicélulas intactas como vectores para transferencia de ADN y terapia génica in vitro e in vivo
EP2272946B9 (en) * 2002-02-25 2015-06-24 Vaxiion Therapeutics, LLC Minicell compositions and methods
US7611885B2 (en) * 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
JP4332558B2 (ja) * 2003-12-09 2009-09-16 エンジーンアイシー モレキュラー デリバリー ピーティーワイ リミテッド 細菌由来のインタクトなミニ細胞を介した非食作用性哺乳動物細胞への標的化遺伝子送達
US8772013B2 (en) * 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
US7124679B2 (en) * 2004-08-25 2006-10-24 L&P Property Management Company Lower guide track for down packing press apparatus and method
US8691963B2 (en) * 2004-08-26 2014-04-08 Engeneic Molecular Delivery Pty. Ltd. Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
PT2040725E (pt) * 2006-06-23 2014-04-24 Engeneic Molecular Delivery Pty Ltd Distribuição dirigida de fármacos, ácidos nucleicos terapêuticos e ácidos nucleicos funcionais a células de mamífero através de células bacterianas mortas intactas

Also Published As

Publication number Publication date
CN102172406B (zh) 2013-03-13
EP2302063A3 (en) 2011-05-25
EP1446489B1 (en) 2012-01-18
US20050222057A1 (en) 2005-10-06
CN102172406A (zh) 2011-09-07
EP2302063A2 (en) 2011-03-30
HK1156069A1 (zh) 2012-06-01
CA2463631A1 (en) 2003-04-24
EP2302063B1 (en) 2016-05-04
WO2003033519A3 (en) 2003-09-25
EP1446489A2 (en) 2004-08-18
DK1446489T3 (da) 2012-05-14
US20080188436A1 (en) 2008-08-07
WO2003033519A2 (en) 2003-04-24
CA2775218A1 (en) 2003-04-24
ES2380612T3 (es) 2012-05-16
US20080020441A1 (en) 2008-01-24
ES2584305T3 (es) 2016-09-27
AU2002347426B2 (en) 2007-05-10
PT1446489E (pt) 2012-04-24
ATE541940T1 (de) 2012-02-15
CN1599797A (zh) 2005-03-23
JP2005505296A (ja) 2005-02-24
CA2775218C (en) 2016-04-26
CA2463631C (en) 2012-07-03
EP1446489A4 (en) 2006-09-06
JP4458846B2 (ja) 2010-04-28
US20120208866A1 (en) 2012-08-16

Similar Documents

Publication Publication Date Title
HK1156069A1 (zh) 用作體外和體內 轉染與基因治療載體的完整微細胞
US6143527A (en) Chain reaction cloning using a bridging oligonucleotide and DNA ligase
IL103677A0 (en) Expression vectors for gene therapy
PL352332A1 (en) Expression and export of interferon-alpha proteins as fc fusion proteins
TW200516144A (en) Novel bone mineralization proteins, DNA, vectors, expression systems
IL206293A0 (en) Genetically engineered duckweed
CA2321964A1 (en) Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus
IL148152A0 (en) Sequence-specific dna recombination in eukaryotic cells
RU94034733A (ru) Способ получения клонирования и экспрессии гена, гены, иммунотоксины, продукты генов, днк, клетка, способ проверки гена и способ коррекции мутаций
EP0382762B1 (en) Synthetic gene
EP0009930B2 (en) Recombinant dna, method for preparing it and production of foreign proteins by unicellular hosts containing it
KR20210123309A (ko) Crispr 활성을 조절하는 시스템 및 방법
US6921816B2 (en) Chimerical peptide-nucleic acid fragment, process for producing the same and its for appropriately introducing nucleic acids into cell organelles and cells
AU5318496A (en) Adenovirus vectors for gene therapy
WO2003000881A3 (en) Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene
AU5728399A (en) Method for transformation of animal cells
WO2002098455A3 (en) Production of recombinant human arylsulfatase a
AU699919B2 (en) Method for increasing plasmid yield
KR940004543B1 (ko) 이.콜라이의 trp 발현 시스템을 갖는 벡터를 제조하는 방법
CN118109494A (zh) 一种构建含有mRNA体外转录元件的通用型mRNA体外转录模版骨架
WO2002010375A1 (fr) Sequence genique de tete d'origine humaine, vecteur genetique et procede d'expression dudit gene
DE69922071D1 (de) Tumor-suppressorgen Del-27 und das dadurch kodierte Protein, verfahren zu deren Herstellung und Nutzung
JPS61170392A (ja) 合成ポリヌクレオチド断片
JPH0644868B2 (ja) Ａｔｐシンターゼのサブユニットｃ用の大腸菌のエー・ティー・ピー・オペロンのインターシストロン性ｄｎａ配列を含むｄｎａ、それを有する発現ベクター及びバクテリア
JPH0559701B2 (pt)